{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:56:09Z","timestamp":1783137369927,"version":"3.54.6"},"reference-count":136,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajog.2020.05.051","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T11:23:54Z","timestamp":1591010634000},"page":"820-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms"],"prefix":"10.1016","volume":"223","author":[{"given":"Nathan G.","family":"Kase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Gretz Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chifei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"LeRoith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.05.051_bib1","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2019.02.051","article-title":"Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy","volume":"221","author":"Desai","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.051_bib2","first-page":"355","article-title":"Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study","volume":"30","author":"Arthur","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajog.2020.05.051_bib4","article-title":"U.S. Cancer Statistics Data Visualizations Tool, based on November 2018 submission data (1999-2016):","year":"2019","journal-title":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute"},{"key":"10.1016\/j.ajog.2020.05.051_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine cancer incidence and mortality \u2013 United States, 1999\u20132016","volume":"67","author":"Henley","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2020.05.051_bib7","series-title":"Comprehensive gynecology","first-page":"968","author":"Lobo","year":"2016"},{"key":"10.1016\/j.ajog.2020.05.051_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.mcna.2011.06.001","article-title":"The metabolic syndrome\u2014from insulin resistance to obesity and diabetes","volume":"95","author":"Gallagher","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ajog.2020.05.051_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00030.2014","article-title":"Obesity and diabetes: the increased risk of cancer and cancer-related mortality","volume":"95","author":"Gallagher","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajog.2020.05.051_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/1055-9965.EPI-19-0206","article-title":"Insulin resistance in healthy U.S. adults: findings from the National Health and Nutrition Examination Survey (NHANES)","volume":"29","author":"Caporaso","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2020.05.051_bib11","first-page":"1","article-title":"Mortality in the United States, 2015","volume":"267","author":"Xu","year":"2016","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2020.05.051_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/aje\/153.9.865","article-title":"Factors associated with age at natural menopause in a multiethnic sample of midlife women","volume":"153","author":"Gold","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2020.05.051_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.05.051_bib16","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.05.051_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2008-0701","article-title":"Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study","volume":"94","author":"Lee","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2013-4465","article-title":"Advanced glycation end-products: pathway of potentially significant pathophysiological and therapeutic relevance for metabolic syndrome in menopausal women","volume":"99","author":"Merhi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm0106-43","article-title":"The humoral side of insulin resistance","volume":"12","author":"Lazar","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.325_256","article-title":"Insulin resistance. Prosperity\u2019s plague","volume":"325","author":"Taubes","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.05.051_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13952","article-title":"Aging, the menopausal transition, and hormone replenishment therapy: retrieval of confidence and compliance","volume":"1440","author":"Saul","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajog.2020.05.051_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women\u2019s lives","volume":"118","author":"Woods","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib25","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2014.08.016","article-title":"Magnitude of the impact of hot flashes on sleep in perimenopausal women","volume":"102","author":"de Zambotti","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.051_bib26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/GME.0000000000000196","article-title":"Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort","volume":"21","author":"Freeman","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2020.05.051_bib27","series-title":"FRAX-based estimates of 10-year probability of hip and major osteoporotic fracture among adults aged 40 and over: United States, 2013 and 2014. National health statistics reports; no 103","author":"Looker","year":"2017"},{"issue":"Suppl 2","key":"10.1016\/j.ajog.2020.05.051_bib28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00198-004-1702-6","article-title":"Epidemiology of osteoporotic fractures","volume":"16","author":"Johnell","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajog.2020.05.051_bib29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.berh.2005.06.010","article-title":"How to manage osteoporosis after the menopause?","volume":"19","author":"Compston","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ajog.2020.05.051_bib30","first-page":"e28","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.05.051_bib31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib32","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41467-019-11558-2","article-title":"A\u00a0meta-analysis of genome-wide association studies identifies multiple longevity genes","volume":"10","author":"Deelen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2020.05.051_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","article-title":"From discoveries in ageing research to therapeutics for healthy ageing","volume":"571","author":"Campisi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.05.051_bib34","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMra1402513","article-title":"The key role of epigenetics in human disease prevention and mitigation","volume":"378","author":"Feinberg","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","article-title":"The roles of DNA, RNA and histone methylation in ageing and cancer","volume":"20","author":"Michalak","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7 Suppl 1","key":"10.1016\/j.ajog.2020.05.051_bib36","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement","volume":"95","author":"Santen","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib37","first-page":"4677","article-title":"Estrogen: consequences and implications of human mutations in synthesis and action","volume":"84","author":"Grumbach","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(96)90075-6","article-title":"Age at menopause as a risk factor for cardiovascular mortality","volume":"347","author":"van der Schouw","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.05.051_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/GME.0000000000001143","article-title":"Menopause versus chronologic aging: their roles in women\u2019s health","volume":"25","author":"Thurston","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2020.05.051_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.ajog.2020.05.051_bib41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib43","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa1006992","article-title":"Adolescent BMI trajectory and risk of diabetes versus coronary disease","volume":"364","author":"Tirosh","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib44","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2003-030242","article-title":"The emergence of the metabolic syndrome with menopause","volume":"88","author":"Carr","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib45","first-page":"1","article-title":"Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003\u20132006","volume":"13","author":"Ervin","year":"2009","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.ajog.2020.05.051_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/er.2016-1146","article-title":"Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications","volume":"38","author":"Mauvais-Jarvis","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2020.05.051_bib47","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.21.10.1589","article-title":"Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal estrogen\/progestin interventions","volume":"21","author":"Espeland","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2020.05.051_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the heart and estrogen\/progestin replacement study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib50","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women\u2019s Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajog.2020.05.051_bib51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women\u2019s Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women\u2019s Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2008.25","article-title":"Increased visceral fat and decreased energy expenditure during the menopausal transition","volume":"32","author":"Lovejoy","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajog.2020.05.051_bib55","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003\u20132012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.05.051_bib57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014 a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.05.051_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-89-2-157","article-title":"Menopause and coronary heart disease. The Framingham Study","volume":"89","author":"Gordon","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.95.1.252","article-title":"Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture","volume":"95","author":"Barrett-Connor","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2020.05.051_bib62","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women","volume":"117","author":"Grady","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib63","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","article-title":"Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?","volume":"54","author":"Matthews","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ajog.2020.05.051_bib64","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib65","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.05.051_bib66","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ajp.20693","article-title":"Coronary heart disease of females: lessons learned from nonhuman primates","volume":"71","author":"Clarkson","year":"2009","journal-title":"Am J Primatol"},{"key":"10.1016\/j.ajog.2020.05.051_bib67","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib68","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJM200511173532020","article-title":"Obesity and mortality","volume":"353","author":"Calle","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1373\/clinchem.2017.277376","article-title":"Obesity and cancer: evidence, impact, and future directions","volume":"64","author":"Colditz","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2020.05.051_bib70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/dme.13301","article-title":"Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes","volume":"34","author":"Park","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2337\/dc12-1020","article-title":"InterAct Consortium. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study","volume":"36","author":"Brand","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2020.05.051_bib72","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/dc13-1986","article-title":"Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women","volume":"37","author":"Appiah","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2020.05.051_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5122(97)00051-0","article-title":"Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile","volume":"28","author":"Malacara","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2020.05.051_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/GME.0000000000000714","article-title":"Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women\u2019s Health Initiative","volume":"24","author":"LeBlanc","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2020.05.051_bib75","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1172\/JCI105588","article-title":"Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries","volume":"46","author":"Bardin","year":"1967","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.05.051_bib76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-5122(81)90028-1","article-title":"Production rates of androgens and oestrogens in post-menopausal women","volume":"3","author":"Longcope","year":"1981","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2020.05.051_bib77","series-title":"Altechek\u2019s diagnosis and management of ovarian disorders","first-page":"291","article-title":"Menopause","author":"Kase","year":"2013"},{"key":"10.1016\/j.ajog.2020.05.051_bib78","first-page":"2832","article-title":"A\u00a0prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition","volume":"85","author":"Burger","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0015-0282(16)56810-1","article-title":"The climacteric ovary as a functional gonadotropin-driven androgen-producing gland","volume":"62","author":"Adashi","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.05.051_bib80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jsbmb.2014.06.001","article-title":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","volume":"145","author":"Labrie","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajog.2020.05.051_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2018.10.004","article-title":"Local estrogen metabolism (intracrinology) in endometrial cancer: a systematic review","volume":"489","author":"Cornel","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajog.2020.05.051_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajog.2020.05.051_bib83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.2004-0020","article-title":"Estrogen\u2014the good, the bad, and the unexpected","volume":"26","author":"Simpson","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2020.05.051_bib84","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women\u2019s Health Initiative randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib85","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/AOG.0b013e3181bea950","article-title":"Endometrial cancer in postmenopausal women using estradiol-progestin therapy","volume":"114","author":"Jaakkola","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.05.051_bib86","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/jama.2019.5346","article-title":"Menopausal hormone therapy","volume":"321","author":"Shifren","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib87","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2020.05.051_bib88","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/gme.0b013e31826f80e0","article-title":"Coronary heart disease events in the Women\u2019s Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women\u2019s Health Initiative randomized clinical trials","volume":"20","author":"Wild","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2020.05.051_bib89","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib90","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1210\/en.2018-00574","article-title":"Diabetes, obesity, and breast cancer","volume":"159","author":"Kang","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2020.05.051_bib91","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2020.05.051_bib92","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2020.05.051_bib93","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/dc14-1996","article-title":"Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation","volume":"38","author":"Harding","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2020.05.051_bib94","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2020.05.051_bib95","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2020.05.051_bib96","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.05.051_bib97","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4158\/EP13248.CS","article-title":"Diabetes and cancer\u2014an AACE\/ACE consensus statement","volume":"19","author":"Handelsman","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2020.05.051_bib98","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2010.06.007","article-title":"The proliferating role of insulin and insulin-like growth factors in cancer","volume":"21","author":"Gallagher","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib99","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2020.05.051_bib100","first-page":"1096","article-title":"Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3\/NovH), an additional member of the IGFBP superfamily","volume":"84","author":"Burren","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.05.051_bib101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1006806722619","article-title":"The IRS-signalling system: a network of docking proteins that mediate insulin action","volume":"182","author":"White","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajog.2020.05.051_bib102","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajog.2020.05.051_bib103","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/bies.200800210","article-title":"Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor","volume":"31","author":"Ward","year":"2009","journal-title":"BioEssays"},{"key":"10.1016\/j.ajog.2020.05.051_bib104","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes","volume":"15","author":"Fern\u00e1ndez","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajog.2020.05.051_bib105","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1158\/0008-5472.CAN-09-2141","article-title":"Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes","volume":"70","author":"Novosyadlyy","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2020.05.051_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ghir.2012.04.001","article-title":"Quantifying insulin receptor isoform expression in FFPE breast tumors","volume":"22","author":"Harrington","year":"2012","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ajog.2020.05.051_bib107","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/srep01491","article-title":"A\u00a0polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components","volume":"3","author":"Chiefari","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2020.05.051_bib108","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/0008-5472.CAN-09-1212","article-title":"The high mobility group A1 gene: transforming inflammatory signals into cancer?","volume":"70","author":"Resar","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2020.05.051_bib109","doi-asserted-by":"crossref","first-page":"e63419","DOI":"10.1371\/journal.pone.0063419","article-title":"HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells","volume":"8","author":"Shah","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.05.051_bib110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1096\/fj.00-0190com","article-title":"Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y)","volume":"15","author":"Brunetti","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2020.05.051_bib111","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-11-0074","article-title":"Insulin receptor and cancer. Endocr Relat Cancer","volume":"18","author":"Belfiore","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ajog.2020.05.051_bib112","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","article-title":"Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis","volume":"123","author":"Protani","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajog.2020.05.051_bib113","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","article-title":"Triple-negative breast cancer: disease entity or title of convenience?","volume":"7","author":"Carey","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajog.2020.05.051_bib114","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/bcr2904","article-title":"Luminal-B breast cancer and novel therapeutic targets","volume":"13","author":"Tran","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajog.2020.05.051_bib115","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1158\/0008-5472.CAN-08-2755","article-title":"Phosphorylated insulin-like growth factor-i\/insulin receptor is present in all breast cancer subtypes and is related to poor survival","volume":"68","author":"Law","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2020.05.051_bib116","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2020.05.051_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170084","article-title":"Diabetes and breast cancer subtypes","volume":"12","author":"Bronsveld","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.05.051_bib118","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajog.2020.05.051_bib119","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.05.051_bib120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/me.2013-1011","article-title":"Minireview: obesity and breast cancer: a tale of inflammation and dysregulated metabolism","volume":"27","author":"Simpson","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajog.2020.05.051_bib121","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ajog.2020.05.051_bib122","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.05.051_bib123","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-med-051613-012328","article-title":"Impact of the obesity epidemic on cancer","volume":"66","author":"Goodwin","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajog.2020.05.051_bib125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10911-013-9302-8","article-title":"Leptin and adiponectin: emerging therapeutic targets in breast cancer","volume":"18","author":"Surmacz","year":"2013","journal-title":"J\u00a0Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ajog.2020.05.051_bib126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ecl.2006.06.002","article-title":"Diabetic dyslipidemia","volume":"35","author":"Chahil","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ajog.2020.05.051_bib127","first-page":"823849","article-title":"Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses","volume":"2013","author":"Melvin","year":"2013","journal-title":"J\u00a0Cancer Epidemiol"},{"key":"10.1016\/j.ajog.2020.05.051_bib128","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"2013","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2020.05.051_bib129","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.05.051_bib130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/bjc.2013.342","article-title":"Statin use in primary inflammatory breast cancer: a cohort study","volume":"109","author":"Brewer","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2020.05.051_bib131","first-page":"559","article-title":"Effect of statins on breast cancer recurrence and mortality: a review","volume":"9","author":"Van Wyhe","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.ajog.2020.05.051_bib132","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2020.05.051_bib133","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fendo.2018.00807","article-title":"Cholesterol and its metabolites in tumor growth: therapeutic potential of statins in cancer treatment","volume":"9","author":"Chimento","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2020.05.051_bib134","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.05.051_bib135","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2017.247","article-title":"Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia","volume":"36","author":"Gallagher","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ajog.2020.05.051_bib136","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ajog.2020.05.051_bib137","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.chemphyslip.2017.05.012","article-title":"27-Hydroxycholesterol: a novel player in molecular carcinogenesis of breast and prostate cancer","volume":"207","author":"Marwarha","year":"2017","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.ajog.2020.05.051_bib138","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-016-0713-5","article-title":"Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer","volume":"18","author":"Simigdala","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajog.2020.05.051_bib139","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/GME.0000000000001424","article-title":"The menopause transition and women\u2019s health at midlife: a progress report from the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"26","author":"El Khoudary","year":"2019","journal-title":"Menopause"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820306074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820306074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:30:03Z","timestamp":1757590203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820306074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":136,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0002937820306074"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.05.051","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}